B. Sanner (Wuppertal, Germany), P. Priou (Angers, France), F. Campos-Rodriguez (Sevilla, Spain), T. Bitter (Bad Oeynhausen, Germany)
LATE-BREAKING ABSTRACT: Usefulness of SD-101 for screening of sleep apnea syndrome
N. Hazeki, K. Kobayashi, Y. Ishikawa, A. Morimoto, Y. Nishimura (Kobe, Japan)
|   |
LATE-BREAKING ABSTRACT: Effect of CPAP treatment on blood pressure levels in resistant hypertension. A multicenter randomized study from the Spanish sleep network (NCT00616265)
M. A. Martínez-García, F. Capote, F. Campos-Rodriguez, P. Lloberes, M. J. Diaz de Atauri, M. Somoza, F. Masa, M. Gonzalez, L. Sacristan, F. Barbé, J. Duran-Cantolla, J. M. Montserrat, On Behalf of Spanish Sleep Network (Valencia, Seville, Barcelona, Madrid, Terrassa, Cáceres, Santander, Alicante, Lleida, Vitoria, Spain)
| |
LATE-BREAKING ABSTRACT: Association between sleep apnoea and cancer mortality. Longitudinal muticenter study in 5,467 patients from the Spanish cohort
M. A. Martínez-García, F. Campos-Rodriguez, J. Duran-Cantolla, M. Gonzalez, M. de la Peña, M. J. Masdeu, F. del Campo, R. Farré, F. Barbé, J. M. Marín, M. Martinez-Alonso, J. M. Montserrat (Valencia, Seville, Vitoria, Santander, Palma de Mallorca, Sabadell, Valladolid, Barcelona, Lleida, Zaragoza, Spain)
| |
LATE-BREAKING ABSTRACT: One-year adherence to CPAP treatment in cardiac patients with non-sleepy sleep apnoea in the RICCADSA trial
Y. Peker, Y. Turgut Celen, A. Stålkrantz, H. Glantz, O. Sengören Dikis, B. Cederin, S. Korkmaz, E. Thunström (Skövde, Gothenburg, Sweden)
| |
Association of cardiovascular diseases, metabolic syndrome and obstructive sleep apnea: Data from 1,000 Japanease PSG cases
A. Matsuo, M. Kosaka, N. Kobayashi, T. Horiuchi, T. Agatsuma, A. Ushiki, S. Kanda, K. Keishi (Nagano, Matsumoto, Japan)
| |
Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS)
L. Jonczak, A. Nowinski, R. Plywaczewski, D. Korzybski, A. Czyzak-Gradkowska, M. Targowska, D. Górecka, P. Sliwinski (Warsaw, Poland)
| |
Heart rate variability by sleep stage at different parts of the night in obstructive sleep apnea
R. Trimer, F. Sousa Melo Costa, R. Gonçalves Mendes, A. Delfino, L.M. Malosa Sampaio, A. Borghi-Silva (Sao Carlos, Brazil)
| |
Diabetes mellitus and obstructivesleep apnea syndrome in primary care
G. Coimbra dos Reis, V. Sacramento, V. Fonseca, C. Alves, I. Ferro, M. Guedes, P. Quintas, R. Marques, J. Cabrita, A. Pinto Saraiva (Barreiro, Lisbon, Portugal)
| |
Resistant arterial hypertension and obstructive sleep apnea syndrome
J. Vale, E. Silva, V. Melo, C. Capelão, A. R. Oliveira, I. Gil, P. Ribeiro, A. Sanchez Serrano, F. Girão, A. Simões Torres (Viseu, Portugal)
| |
Urinary excretion of erythropoietin in sleep apnea-hypopnea syndrome
C. Estirado, N. Grau, M.A. Felez, L. Sanchez Torner, E. Guardiola, A. Ruiz Cano, C. Sanjuás, A. Pascual, M. Orozco-Levi (Barcelona, Spain; Floridablanca, Colombia)
| |
Left ventricular function assessment in patients with obstructive sleep apnea syndrome
R. El Wahsh, R. Bakr, M. Ahmed, R. Yaseen (Shebin El Kom, Egypt)
| |
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
T. Penzel, C. Schöbel, C. Garcia, M. Glos, N. Wessel, I. Fietze (Berlin, Germany)
| |
Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
S. Wiscombe, J. Newton, C. Day, J. Gibson, S. West (Newcastle-upon-Tyne, United Kingdom)
| |